Calidi Biotherapeutics
- Biotech or pharma, therapeutic R&D
Calidi is developing RedTail, a platform for the systemic delivery of a modified oncolytic virus that an also deliver a genetic payload to the tumor site. CLD-401, the first lead from the RedTail platform, is in IND-enabling studies and expects to enter the clinic next year.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}